Sanders likely to chair Senate health panel, reshaping FDA oversight

Sen. Bernie Sanders is expected to take the helm of the Senate health committee, giving him a platform to push for single-payer reforms and alter FDA-industry relations. The shift signals a more aggressive regulatory posture toward drug pricing and approval processes, though legislative impact remains uncertain given narrow margins.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works